July 11, 2024 02:59 PM EDT
Pharma
FDA+

Sen­ate unan­i­mous­ly pass­es bi­par­ti­san phar­ma patent bill

Zachary Brennan

Senior Editor

The Sen­ate in a unan­i­mous vote Thurs­day af­ter­noon passed a bill that aims to tack­le phar­ma­ceu­ti­cal patent abus­es by lim­it­ing the num­ber of patents that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times